
COURSE CREDITS & HOURS
21 AMA PRA Category 1 Credits™21 ANCC Contact Hours
11 Hours of Pharmacology for NPs
COURSE FEES
TARGET AUDIENCE
PROGRAM TOPICS
- Obese patient: root cause analysis and approach to treatment from lipidologist perspective
- Identify medical factors, medication, insulin resistance as secondary causes of obesity and approach to work up.
- Discuss how diet, genomics, microbiome and environmental factors influence the treatment of obese patients.
- Review new medications FDA approved for treament of obesity
- Diabetes medications and new Treatment options, including Cardiovascular outcomes data
- Review approach to treatment of diabetes, including discussion new cardiovascular outcomes data for GLP 1 agonists, SGT2 inh, Quick release bromocriptine
- Biomarkers: Role of Apo B, lp (a), LDL-P vs LDL -C in primary and secondary prevention cardiovascular disease, also inflammation and role in women's cv health
- Discuss outcomes data for Apo B, LDL P and cost effective approach to treatment of residual risk
- Describe concept of concordance and discordance of DLL cholesterol vs LDL particles or Apo B and clinical application
- Management of complex dyslipidemia including Lowering triglycerides and raising HDL Cholesterol, does it matter?
- Review lipid treatment guidelines
- Review clinical impact of HDL c raising trials including AIM HIGH and HPS 2thrive
- Review of TG lowering therapies and outcome data
- Discuss new LDL lowering therapies including PCSK9 inhibitors
- Case studies in cardiometabolic disease: focus on women throughout lifespan
- Review treatment of genetic disorders in women of childbearing age, children and adolescents, Postmenopausal women
- Learn specific clinical applications through use of real case
- Polycystic ovarian Syndrome
- Review the cardiometabolic risks related to PCOS, approach to treament of symptoms and CV prevention
- Microbiome Role in metabolic health
- Discuss role of microbiome in health and disease across the lifespan including mode of delivery (c section vs vaginal), use of antiobiotics, dietary choices
- Supplements for disease prevention: omega 3, vit D, folate
- Discuss data behind use of supplements, and role of deficienies in chronic disease.
- Discuss impact of MTHFR on womens health and supplementation
- Preventive Medcine From A to Z
- Discuss state-of-the-art cardiovascular and global preventative medicine principles
- Reaching the 2018 Blood Pressure Goals--A Focus on Isolated Systolic and Resistant Hypertension
- Differentiate methods to diagnose resistant hypertension and achieve treatment goals
- The Impact of Recent Clinical Trials on Preventative Cardiology in the Office-Let's Make the Cardiologist as Lonely as the Maytag Repairman
- Appropriately apply primary and secondary cardiovascular prevention goals
- Travel Medicine-Staying Well Away From Home
- Analyze a patient's requirements for prevention and treatment of travel-related health problems
- The Bipolar Blues, Balls of Fire, and Bad Temperament - How to Bag the Diagnosis and Benefit the Patient
- Feel more confident in differentiating between unipolar and bipolar mood disorders
- The Utility of Heart Scans for Detecting Subclinical CHD and the Primary Prevention of Coronary Heart Disease
- Utilize coronary artery calcium scores to design appropriate primary CHD prevention strategies
- Defeating Dementia - What Can WE Do?
- Explain diagnostic, treatment, and prevention strategies for Alzheimer's disease and vascular dementia
- Male Osteoporosis-A Case Study of Weak Struts, Linoleum, Rice Cakes, and 8 Clicks
- Integrate knowledge regarding the diagnosis and treatment of male osteoporosis
- Is Something FISHY Here? The FACTS about Marine Oils and Cardiovascular Disease Prevention
- Understand omega-3 fatty acids and their possible role in disease prevention
- Carotid and Abdominal Ultrasounds for Detecting Subclinical Carotid Artery Disease and Abdominal Aortic Aneurysms-Does it Make a Difference
- Utilize the clinical values of detecting and treating subclinical carotid artery disease and aortic vascular disease








































